Stockreport

Decoy Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement [TheStreet.com]

Decoy Therapeutics Inc.  (DCOY) 
PDF CAMBRIDGE, Mass. and HOUSTON April 2, 2026 /PRNewswire/ -- Decoy Therapeutics, Inc. (Nasdaq: DCOY) (Decoy, or the Company), announces that on March 31, 2026 the Company [Read more]